HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatima Amanat Selected Research

Neutralizing Antibodies

3/2024Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination.
1/2022The IgA in milk induced by SARS-CoV-2 infection is comprised of mainly secretory antibody that is neutralizing and highly durable over time.
12/2021Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
11/2021Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern.
5/2021The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.
1/2021Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.
1/2021SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.
12/2020Robust neutralizing antibodies to SARS-CoV-2 infection persist for months.
10/2020A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
8/2020Quantifying absolute neutralization titers against SARS-CoV-2 by a standardized virus neutralization assay allows for cross-cohort comparisons of COVID-19 sera.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fatima Amanat Research Topics

Disease

49COVID-19
01/2023 - 01/2020
36Infections
03/2024 - 01/2016
8Inflammation (Inflammations)
01/2022 - 07/2020
6Human Influenza (Influenza)
12/2020 - 10/2017
5Vesicular Stomatitis
01/2021 - 01/2017
5Virus Diseases (Viral Diseases)
01/2021 - 11/2017
2Pneumonia (Pneumonitis)
01/2021 - 01/2021
2Diarrhea
01/2021 - 12/2020
1Type I Syndactyly
03/2024
1Breakthrough Infections
01/2023
1Measles
12/2021
1Weight Loss (Weight Reduction)
11/2021
1Convalescence
11/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
02/2021
1Emerging Communicable Diseases (Emerging Infectious Diseases)
11/2020
1Vaccinia
07/2020
1Severe Acute Respiratory Syndrome
04/2020
1Fever (Fevers)
05/2018

Drug/Important Bio-Agent (IBA)

31VaccinesIBA
01/2023 - 01/2017
25AntibodiesIBA
01/2023 - 01/2016
15Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2018
13Neutralizing AntibodiesIBA
03/2024 - 01/2020
9Hemagglutinins (Hemagglutinin)IBA
01/2020 - 01/2016
7CytokinesIBA
12/2022 - 07/2020
7Immunoglobulin A (IgA)IBA
01/2022 - 07/2020
7EpitopesIBA
12/2021 - 05/2018
7Immunoglobulin G (IgG)IBA
08/2021 - 01/2018
6Neuraminidase (Sialidase)IBA
12/2021 - 01/2016
6Glycoproteins (Glycoprotein)IBA
03/2021 - 01/2017
5Influenza Vaccines (Influenza Vaccine)FDA Link
01/2021 - 01/2017
5Antiviral Agents (Antivirals)IBA
12/2020 - 01/2017
4AntigensIBA
01/2022 - 07/2020
4Monoclonal AntibodiesIBA
12/2021 - 01/2016
4Immunoglobulin M (IgM)IBA
08/2021 - 07/2020
4Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2020
3Immunoglobulins (Immunoglobulin)IBA
01/2023 - 12/2020
3Messenger RNA (mRNA)IBA
01/2023 - 10/2020
3COVID-19 VaccinesIBA
01/2023 - 07/2020
3ChAdOx1 nCoV-19IBA
01/2023 - 01/2021
3mRNA VaccinesIBA
01/2022 - 10/2020
3Interleukin-10 (Interleukin 10)IBA
01/2021 - 12/2020
3RNA (Ribonucleic Acid)IBA
01/2021 - 12/2020
2Secretory Immunoglobulin A (SIgA)IBA
01/2022 - 11/2020
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2022 - 08/2021
2ChemokinesIBA
01/2022 - 08/2021
2Ad26COVS1IBA
11/2021 - 01/2021
2LipidsIBA
07/2021 - 01/2021
2Immunoglobulin IsotypesIBA
01/2021 - 12/2020
2NucleoproteinsIBA
01/2021 - 01/2021
2poly(oxyethylene) cholesteryl etherIBA
01/2021 - 10/2020
2Interleukin-8 (Interleukin 8)IBA
01/2021 - 12/2020
2Interleukin-23 (Interleukin 23)IBA
01/2021 - 12/2020
2Viral RNAIBA
01/2021 - 12/2020
1Fc Receptors (Fc Receptor)IBA
01/2023
1Interleukin-27 (Interleukin 27)IBA
12/2022
1Transcription Factors (Transcription Factor)IBA
12/2021
1PhosphoproteinsIBA
12/2021
1Peptides (Polypeptides)IBA
11/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
11/2021
1NDV-HXP-S COVID-19 vaccineIBA
10/2021
1remdesivirIBA
08/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Ligases (Synthetase)IBA
01/2021
1Antigen-Antibody Complex (Immune Complex)IBA
01/2021
1SARS-CoV-2 spike proteinIBA
01/2021
1AlbuminsIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Renilla LuciferasesIBA
01/2021
1Oxygen (Dioxygen)IBA
11/2020
1NucleosidesIBA
10/2020
1AutoantibodiesIBA
07/2020
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2020
1Nucleic AcidsIBA
01/2020
1Surface Antigens (Surface Antigen)IBA
01/2020
1Viral HemagglutininsIBA
01/2019
1Carrier Proteins (Binding Protein)IBA
10/2017
1Oseltamivir (Tamiflu)FDA Link
01/2017

Therapy/Procedure

6Therapeutics
01/2021 - 01/2020
2Drug Therapy (Chemotherapy)
01/2022 - 08/2021
1Immunotherapy
01/2021
1Ambulatory Care (Outpatient Care)
01/2021